Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS CoV2 infection and long COVID.

Matthew PlassmeyerOral AlpanMichael J CorleyThomas A PremeauxKimberleigh LillardPaige CoatneyTina VaziriSuzan MichalskyAlina P S PangZaheer BukhariStephen T YeungTeresa H EveringGail NaughtonMartin LatterichPhilip MuddAlfred SpadaNicole RindoneDenise LoizouSøren Ulrik SønderLishomwa C NdhlovuRaavi Gupta

Published in: Allergy (2021)

Pan-caspase inhibition could emerge as a therapeutic strategy to ameliorate or prevent severe COVID-19.

Keyphrases

coronavirus disease
sars cov
cell death
respiratory syndrome coronavirus
early onset
induced apoptosis
drug induced